CTLA4 dimorphisms and the multiple sclerosis phenotype

J Neuroimmunol. 2002 Oct;131(1-2):208-12. doi: 10.1016/s0165-5728(02)00274-6.

Abstract

Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), expressed on activated T cells, binds to B7 molecules on antigen-presenting cells. Signaling via CTLA-4 results in downregulation of ongoing T-cell clonal expansion. A single-nucleotide polymorphism (SNP) in exon 1 of CTLA4 is associated with susceptibility to several autoimmune diseases, including multiple sclerosis (MS). In this two-stage study, we investigated whether haplotypes composed of exon 1-SNP alleles and alleles of a promoter-region SNP influence age at onset, disease severity and disease course in MS. In stage 1, deviations in CTLA4 haplotype frequencies were observed in patients subgrouped by course; in stage 2, none of these original associations were confirmed.

MeSH terms

  • Abatacept
  • Age of Onset
  • Antigens, CD
  • Antigens, Differentiation / genetics*
  • CTLA-4 Antigen
  • Disease Progression
  • Gene Frequency
  • Genotype
  • Haplotypes
  • Humans
  • Immunoconjugates*
  • Multiple Sclerosis / diagnosis*
  • Multiple Sclerosis / genetics*
  • Phenotype
  • Polymorphism, Single Nucleotide*

Substances

  • Antigens, CD
  • Antigens, Differentiation
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Immunoconjugates
  • Abatacept